Lunai Bioworks Inc (LNAI) Stock Price, Quote & News

Company Profile

Lunai Bioworks Inc., a pre-clinical stage biotechnology company, provides medicine, diagnostics, and biodefense products the United States and the Netherlands. It operates through three segments, RENB, BioSymetrics, and RENC. The company is developing a genetically modified allogeneic dendritic cell therapeutic vaccines, including RENB-DC11 to treat solid tumors primarily for pancreatic tumors; and RENB-DC20 for the treatment of breast cancer. It also develops an artificial intelligence platform...

Industry: Biotechnology

Sector: Healthcare

Phone: 305 918 1980

Website: www.lunaibioworks.com

Address:

2080 Century Park East, Suite 906, Los Angeles, United States

MarketForecasting Feb. 3 at 7:15 PM

$LNAI if only you knew what I know of this fraudulent P.O. Box , you would short it with all you have .

1 · Reply

MarketForecasting Feb. 3 at 3:08 PM

$LNAI 🤨😳

0 · Reply

MarketForecasting Feb. 2 at 9:21 PM

$LNAI added to my short here

0 · Reply

11thestate Jan. 30 at 12:37 PM

Imagine buying $ENOB (now $LNAI ) at its peak, only to watch it crash like this — and then finding out there’s a way to get some money back. To all $ENOB (now $LNAI ) investors out there, we’ve got some important news for you: https://11th.com/cases/enochian-biosciences-investor-settlement

0 · Reply

Stengaard1 Jan. 29 at 11:29 PM

$LNAI from the recent investor summary: https://s201.q4cdn.com/863337820/files/doc_presentations/2026/Jan/29/LNAIpresentation2026.pdf.

0 · Reply

Luca3211 Jan. 29 at 11:03 PM

$LNAI

0 · Reply

MarketForecasting Jan. 29 at 2:51 PM

$LNAI bamboozled by thieves , class action lawsuits are the only way for these career criminals .

1 · Reply

frangoGnarly Jan. 28 at 4:39 PM

$LNAI check $MOVE tiny float, great opportunity

0 · Reply

MarketForecasting Jan. 28 at 3:26 PM

$LNAI 🤨

0 · Reply

MarketForecasting Jan. 28 at 2:54 PM

$LNAI short short short , it’s a scam , short short short

0 · Reply

Lunai Bioworks (NASDAQ: LNAI) Launches Sentinel, an AI Safeguard to Block Large Language Models from Generating Novel Chemical Weapons

Jan 26, 2026, 9:30 AM EST - 8 days ago

Lunai Bioworks (NASDAQ: LNAI) Expands NIH-Funded AI Program into Commercial Alcohol Use Disorder Drug Discovery

Dec 18, 2025, 9:00 AM EST - 6 weeks ago

Lunai Bioworks (NASDAQ: LNAI) Featured in International Business Times as AI Partnership Talks Advance

Dec 9, 2025, 7:45 AM EST - 2 months ago

Lunai Bioworks Identifies Three Parkinson's Subtypes and Prioritized Drug Targets to Accelerate Proof-of-Concept Programs and Strategic Partnerships in a $13B Market

Nov 25, 2025, 7:45 AM EST - 2 months ago

Lunai Bioworks Secures First Licensing LOI Following Landmark Breakthrough Showing Complete Tumor Regression in Humanized Cancer Models

Nov 5, 2025, 9:22 AM EST - 3 months ago

Lunai Bioworks achieves complete regression of both primary and metastatic pancreatic tumors in preclinical humanized models, marking a breakthrough in allogeneic cancer immunotherapy

Oct 30, 2025, 9:32 AM EDT - 3 months ago

Lunai Bioworks Harnesses AI and Zebrafish Data to Advance Early Detection of Neurotoxic Compounds

Oct 16, 2025, 9:45 AM EDT - 3 months ago

Landmark Study Identifies Prognostic Biomarkers in Duchenne Muscular Dystrophy Using Large-Scale Serum Proteomics

Oct 16, 2025, 9:15 AM EDT - 3 months ago

Lunai Bioworks Regains Compliance with Nasdaq Minimum Bid Price Requirement

Oct 6, 2025, 9:15 AM EDT - 4 months ago

Lunai Bioworks Launches AI-Powered Alzheimer's Disease Program, Expanding Neurodegenerative Pipeline

Sep 30, 2025, 9:15 AM EDT - 4 months ago

Lunai Bioworks Unveils New Corporate Identity, Streamlined Capital Structure, and Strategic Focus on AI-Powered Therapeutics and Biodefense

Sep 25, 2025, 8:30 AM EDT - 4 months ago

Lunai Bioworks Advances Biomarker Discovery Preclinical Program in Parkinson's Disease, Positioning for Strategic Pharma Partnerships

Sep 24, 2025, 4:50 PM EDT - 4 months ago

Lunai Bioworks, Inc. to Effect 10:1 Reverse Stock Split

Sep 11, 2025, 7:00 AM EDT - 5 months ago

Lunai Bioworks subsidiary BioSymetrics and Brigham and Women's Hospital Awarded NIH STTR Grant to Develop AI-Powered Platform for Alcohol Use Disorder Therapeutics

Sep 9, 2025, 9:12 AM EDT - 5 months ago

Top 3 Health Care Stocks You'll Regret Missing In Q3

SMMT

Sep 9, 2025, 8:47 AM EDT - 5 months ago

Lunai Bioworks Inc. Unveils Transformer Platform to Secure Generative AI and Accelerate Drug Discovery

Sep 8, 2025, 8:50 AM EDT - 5 months ago

Lunai Bioworks Strengthens European Strategy Through Restructuring

Sep 4, 2025, 10:05 AM EDT - 5 months ago

Lunai Bioworks Inc. Retains American Defense International

Aug 27, 2025, 9:45 AM EDT - 5 months ago

Renovaro Inc. Announces Corporate Name Change to Lunai Bioworks, Inc., Reflecting Strategic Focus on AI-Driven Biodefense, Drug Discovery and Advanced Diagnostics

Aug 8, 2025, 10:45 AM EDT - 6 months ago

Renovaro Inc. (NASDAQ: RENB) Mentioned in RealClearDefense Article on AI and Biodefense Risks

Jul 28, 2025, 10:38 AM EDT - 6 months ago

Renovaro Secures Key AI Patents, Strengthening Market Position in $20B Biomedical AI Sector

Jul 17, 2025, 9:15 AM EDT - 7 months ago

Peer-Reviewed Study Validates Renovaro's Genetically Engineered Dendritic Cell Therapy with Potent Anti-Tumor Efficacy

Jul 9, 2025, 8:00 AM EDT - 7 months ago

Renovaro Strengthens Balance Sheet Through Debt Conversion and Advances AI-Driven Initiatives

Jun 30, 2025, 9:21 AM EDT - 7 months ago

Renovaro Launches AI-Based Neurotoxin Countermeasure Initiative Addressing Emerging National Security Needs

Jun 3, 2025, 9:15 AM EDT - 8 months ago

Renovaro Secures Key U.S. Patent to Strengthen AI-Driven Drug Discovery and Diagnostics Platform

May 22, 2025, 3:12 PM EDT - 9 months ago

UPDATE - Renovaro Inc. Announces Expedited Trial for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology

May 22, 2025, 11:05 AM EDT - 9 months ago

Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology

May 14, 2025, 9:15 AM EDT - 9 months ago

Renovaro Launches Augusta, an AI-Powered Precision Neurology Platform

May 13, 2025, 9:15 AM EDT - 9 months ago

Renovaro and Amsterdam University Medical Center Announce Exclusive Collaboration to Advance Blood Platelet RNA Diagnostics

Apr 22, 2025, 9:20 AM EDT - 10 months ago

Renovaro Secures High-Powered Computing from Nebul Through a Partnership to Accelerate Next-Generation Biomarker Discovery and Diagnostic Programs

Apr 9, 2025, 9:25 AM EDT - 10 months ago

Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision Medicine

Apr 4, 2025, 9:40 AM EDT - 10 months ago

Renovaro Provides Update to Definitive Agreement with Predictive Oncology

Mar 3, 2025, 9:15 AM EST - 1 year ago

Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology

Feb 26, 2025, 1:25 PM EST - 1 year ago

Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine

Feb 26, 2025, 9:15 AM EST - 1 year ago

Renovaro Announces $15 million in Equity Committed

Jan 7, 2025, 6:51 PM EST - 1 year ago

PREDICTIVE ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc. - POAI

Jan 7, 2025, 9:15 AM EST - 1 year ago

Renovaro Appoints Nathen Fuentes as Chief Financial Officer

Jan 7, 2025, 9:15 AM EST - 1 year ago

Renovaro Issues Shareholder Letter and Provides Corporate Update

Jan 6, 2025, 9:15 AM EST - 1 year ago

Renovaro to Acquire Predictive Oncology in All-Stock Transaction

Dec 30, 2024, 9:00 AM EST - 1 year ago

Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV

Dec 23, 2024, 9:00 AM EST - 1 year ago

RenovaroCube Receives Approval of Lumina Project by the Eurostars Funding Program

Dec 20, 2024, 3:40 PM EST - 1 year ago

Renovaro Regains Compliance with NASDAQ Listing Requirement

Dec 20, 2024, 9:00 AM EST - 1 year ago

Renovaro Enters into a Strategic Collaboration with Nebul to Advance a Paradigm Shift for Early Disease Detection

Oct 17, 2024, 9:15 AM EDT - 1 year ago

RenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using Oxford Nanopore Sequencing

Oct 16, 2024, 9:28 AM EDT - 1 year ago

Renovaro Announces Strategic Restructuring and Leadership Transition

Sep 13, 2024, 9:00 AM EDT - 1 year ago

RenovaroCube to Present Cutting-Edge Cancer Diagnostics Research at European Society for Medical Oncology Congress

Sep 11, 2024, 9:15 AM EDT - 1 year ago

RenovaroCube Announces Strategic Offering of Up to 20% Ownership

Jun 14, 2024, 9:06 AM EDT - 1 year ago

Renovaro, Inc. Announces $10 million in Equity Committed

May 24, 2024, 9:20 AM EDT - 1 year ago

Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy

May 21, 2024, 8:39 AM EDT - 1 year ago

Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month - Renovaro (NASDAQ:RENB)

BAX RAPT SAGE TMCI

MarketForecasting Feb. 3 at 7:15 PM

$LNAI if only you knew what I know of this fraudulent P.O. Box , you would short it with all you have .

1 · Reply

MarketForecasting Feb. 3 at 3:08 PM

$LNAI 🤨😳

0 · Reply

MarketForecasting Feb. 2 at 9:21 PM

$LNAI added to my short here

0 · Reply

11thestate Jan. 30 at 12:37 PM

0 · Reply

Stengaard1 Jan. 29 at 11:29 PM

$LNAI from the recent investor summary: https://s201.q4cdn.com/863337820/files/doc_presentations/2026/Jan/29/LNAIpresentation2026.pdf.

0 · Reply

Luca3211 Jan. 29 at 11:03 PM

$LNAI

0 · Reply

MarketForecasting Jan. 29 at 2:51 PM

$LNAI bamboozled by thieves , class action lawsuits are the only way for these career criminals .

1 · Reply

frangoGnarly Jan. 28 at 4:39 PM

$LNAI check $MOVE tiny float, great opportunity

0 · Reply

MarketForecasting Jan. 28 at 3:26 PM

$LNAI 🤨

0 · Reply

MarketForecasting Jan. 28 at 2:54 PM

$LNAI short short short , it’s a scam , short short short

0 · Reply

Luca3211 Jan. 27 at 9:22 PM

$LNAI

0 · Reply

1dk2la Jan. 27 at 4:45 PM

$LNAI funding moves stock price, apparently great pipelines and news doesn't as we have seen over and over again. Funding and/or financial partnership must be around the corner with all this activity. Exciting times

0 · Reply

Stengaard1 Jan. 27 at 4:20 PM

$LNAI $LNAI Sentinel to the rescue… my only question is whether the implementation of Sentinel will be mandatory or voluntary for Google, Siri,OpenAi,Claude, Gemini, Anthropic and the rest of them ;) and how much it will contribute to Lunai’s balancesheet https://u26594104.ct.sendgrid.net/ls/click?upn=u001.FlS-2FmGxfJeaLDC8YowyyFsnPkn98xIycste9eFgk5zwfZLDR1SDTeuSNyTxQvLXly6fFVMUV6igr3oHsQNkPk4xsMhxMNtDvQq5WNEmfN-2F3HOZT-2B1j6olcIaPRp2-2B4dd4didfL0NsN5-2B8wlnsk20lRJxRqVMkqTtVnFRPbjQ75J642QgkBYvTqyujm6-2BT5iXwb03Ayb6uTD3zxMayKtmYYQX1d48QT0f9icuAHHkmuPuit1rcPZWLcZpyiPx34qwCyW3GDKnsPZWMs54CLfjcPXWbvikjqO8EDDfXF0CEwA-3DxKfu_JZaBNX6PzvSUjygPXiTsf7UpVukboZRLI8x8EItZ3vwAH3mvZdd-2BCY8LYjNUSAM51wQMktXopDzApRr6j6XizwD-2FcLrJfdFSPcNNrQke-2F-2F6o8F9TCz5wa00hXOgD901GzopJ3HpcjKkQBpw-2FbwgIUQeDDX5BTX-2FdGqRPcFbPXJxDpLAcawaG3Q-2F9ED-2Frspb3BZRrQcWY0keR-2FUNlJZUDKuKp2BHdO5Kp-2FWYQ7VpKzywUTIBI3QtuxWT0YhUw07Q-2FAmFZL-2BzWd991KDmH4XwzJcr0BVGmPEddUVcEmobAQMzmlqkEP2VDbNpe-2FDFn-2FV6-2FTmF9ytWwuzywts6-2FRFms-2BOyWBkUyCoKnhBvfFmbRVCANFk3DOr4JvQNqkhDFGgEdJVxHZ3qIAsHn2MBawIF20GKnPS2xhAu8IhfYMe6Z-2FyhNWiavpGpevH3ByobylJe4rYs9UjFPldnBWHtBkIPr4OgBHxwYnnaBbdTe-2B5zDpJk-3D

1 · Reply

Stengaard1 Jan. 27 at 3:32 PM

$LNAI in December 2025 in LNAI mentioned their focus on bioweapons (prevention) -- interestingly, this is what the CEO of Anthropic has to say about the very same threat today on CNBC :)

1 · Reply

1dk2la Jan. 26 at 3:24 PM

$LNAI https://ir.lunaibioworks.com/news/news-details/2026/Lunai-Bioworks-NASDAQ-LNAI-Expands-NIH-Funded-AI-Program-into-Commercial-Alcohol-Use-Disorder-Drug-Discovery-2026-eX6Fk8Vezs/default.aspx

2 · Reply

MarketForecasting Jan. 21 at 8:09 PM

$LNAI would love to see this break and get to .30 cents . My short will pay off heavily if that happens . A fraudulent Company with no product no revenue and no employees .

1 · Reply

11thestate Jan. 21 at 3:26 PM

Imagine buying $ENOB at its peak, only to watch it crash like this — and then finding out there’s a way to get some money back. To all $ENOB (now $LNAI ) investors out there, we’ve got some important news for you: https://11th.com/cases/enochian-biosciences-investor-settlement

0 · Reply

Stengaard1 Jan. 15 at 9:25 AM

$LNAI participated in JP Morgans JP Morgan Healthcare Conference - MedTech Showcase presentation: https://s201.q4cdn.com/863337820/files/doc_presentations/2026/Jan/12/JPM_Investor_Deck_010925.pdf JO Morgan do not invite Lunai without validation, the presentation is extremely interesting... One of the slides mentions deals expected in Q1 2026 (and the ret of the year)

3 · Reply

1dk2la Jan. 13 at 9:10 PM

$LNAI https://ir.lunaibioworks.com/events-and-presentations/default.aspx

2 · Reply

1dk2la Jan. 13 at 9:09 PM

$LNAI new impressive presentation just release with timelines and 2026 planning for deals and partnerships

1 · Reply

11thestate Jan. 8 at 6:11 PM

When we see a stock like this, we know how many damaged investors are out there. Believe it or not, there’s some good news. $LNAI / $ENOB investors — you might be surprised, but you actually have a chance to recover your losses. Don’t miss it: https://11th.com/cases/enochian-biosciences-investor-settlement

0 · Reply

Bwaffle Jan. 7 at 7:30 PM

$LNAI scam company Ole Abildgaard has stolen all your money

4 · Reply

Market Cap	18.29M
Revenue (ttm)	0.00
Net Income (ttm)	-178.01M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	185,900
Avg Vol	1,286,356
Day's Range	N/A - N/A
Shares Out	23.43M
Stochastic %K	3%
Beta	0.40
Analysts	Strong Buy
Price Target	N/A